Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies.
Autorzy:
Panagides N; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, QLD 4072, Australia. Zacchi LF; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, QLD 4072, Australia. De Souza MJ; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3052, Australia. MoralesRAV; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3052, Australia. Karnowski A; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3052, Australia. Liddament MT; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3052, Australia. Owczarek CM; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3052, Australia. Mahler SM; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, QLD 4072, Australia. Panousis C; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3052, Australia. Jones ML; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, QLD 4072, Australia. Fercher C; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, QLD 4072, Australia.
Conformational exchange in the potassium channel blocker ShK.
Autorzy:
Iwakawa N; Department of Molecular Engineering, Graduate School of Engineering, Kyoto University, Kyoto-Daigaku Katsura, Nishikyo-Ku, Kyoto, 615-8510, Japan.; Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK. Baxter NJ; Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK. Wai DCC; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia. Fowler NJ; Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK. MoralesRAV; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.; CSL Limited (Bio21), 30 Flemington Road, Parkville, Victoria, 3010, Australia. Sugase K; Department of Molecular Engineering, Graduate School of Engineering, Kyoto University, Kyoto-Daigaku Katsura, Nishikyo-Ku, Kyoto, 615-8510, Japan. Norton RS; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia. .; ARC Centre for Fragment-Based Design, Monash University, Parkville, Victoria, 3052, Australia. . Williamson MP; Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Dec 17; Vol. 9 (1), pp. 19307. Date of Electronic Publication: 2019 Dec 17.
Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation.
Autorzy:
Ikonomopoulou MP; QIMR, Berghofer Medical Research Institute, Herston, QLD, 4002, Australia. .; School of Medicine, The University of Queensland, Herston, QLD, 4006, Australia. .; Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM + CSIC, Madrid, E28049, Spain. . Fernandez-Rojo MA; QIMR, Berghofer Medical Research Institute, Herston, QLD, 4002, Australia.; School of Medicine, The University of Queensland, Herston, QLD, 4006, Australia.; Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM + CSIC, Madrid, E28049, Spain. Pineda SS; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia.; Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, 2052, Australia. Cabezas-Sainz P; Departament of Zoology, Genetics and Physical Anthropology, University of Santiago de Compostela, 27002, Lugo, Spain. Winnen B; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia. MoralesRAV; Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM + CSIC, Madrid, E28049, Spain.; Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Victoria, 3800, Australia. Brust A; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia. Sánchez L; Departament of Zoology, Genetics and Physical Anthropology, University of Santiago de Compostela, 27002, Lugo, Spain. Alewood PF; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia. Ramm GA; QIMR, Berghofer Medical Research Institute, Herston, QLD, 4002, Australia.; School of Medicine, The University of Queensland, Herston, QLD, 4006, Australia. Miles JJ; QIMR, Berghofer Medical Research Institute, Herston, QLD, 4002, Australia.; School of Medicine, The University of Queensland, Herston, QLD, 4006, Australia.; Centre for Biodiscovery and Molecular Development of Therapeutics, AITHM, James Cook University, Cairns, Queensland, Australia. King GF; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2018 Aug 01; Vol. 8 (1), pp. 11519. Date of Electronic Publication: 2018 Aug 01.
Lipid interactions modulate the structural and antigenic properties of the C-terminal domain of the malaria antigen merozoite surface protein 2.
Autorzy:
Das SC; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia. MoralesRAV; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia. Seow J; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia. Krishnarjuna B; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia. Dissanayake R; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia. Anders RF; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia. MacRaild CA; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia. Norton RS; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
Pokaż więcej
Źródło:
The FEBS journal [FEBS J] 2017 Aug; Vol. 284 (16), pp. 2649-2662. Date of Electronic Publication: 2017 Jul 05.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies